Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen
- PMID: 6835382
- DOI: 10.1038/302490a0
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen
Abstract
Potential live vaccines against hepatitis B virus have been produced. The coding sequence for hepatitis B virus surface antigen (HBsAg) has been inserted into the vaccinia virus genome under control of vaccinia virus early promoters. Cells infected with these vaccinia virus recombinants synthesize and excrete HBsAg and vaccinated rabbits rapidly produce antibodies to HBsAg.
Similar articles
-
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.Proc Natl Acad Sci U S A. 1984 Jan;81(1):193-7. doi: 10.1073/pnas.81.1.193. Proc Natl Acad Sci U S A. 1984. PMID: 6320164 Free PMC article.
-
Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen.Vaccine. 1989 Feb;7(1):53-9. doi: 10.1016/0264-410x(89)90011-x. Vaccine. 1989. PMID: 2718607
-
Recombinant vaccinia virus: immunization against multiple pathogens.Science. 1985 Sep 6;229(4717):981-4. doi: 10.1126/science.2992092. Science. 1985. PMID: 2992092
-
Recombinant vaccinia viruses as new live vaccines.Biotechnol Genet Eng Rev. 1984;2:383-407. doi: 10.1080/02648725.1984.10647806. Biotechnol Genet Eng Rev. 1984. PMID: 6100668 Review. No abstract available.
-
Newer directions in vaccine development and utilization.J Infect Dis. 1985 Mar;151(3):407-19. doi: 10.1093/infdis/151.3.407. J Infect Dis. 1985. PMID: 2982958 Review.
Cited by
-
Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy.Infect Immun. 1986 Mar;51(3):879-83. doi: 10.1128/iai.51.3.879-883.1986. Infect Immun. 1986. PMID: 3081446 Free PMC article.
-
Why do poxviruses still matter?Cell Biosci. 2021 May 22;11(1):96. doi: 10.1186/s13578-021-00610-8. Cell Biosci. 2021. PMID: 34022954 Free PMC article. Review.
-
Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.Proc Natl Acad Sci U S A. 1987 Oct;84(19):6854-8. doi: 10.1073/pnas.84.19.6854. Proc Natl Acad Sci U S A. 1987. PMID: 3477812 Free PMC article.
-
Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized in E. coli.EMBO J. 1985 Dec 1;4(12):3339-43. doi: 10.1002/j.1460-2075.1985.tb04086.x. EMBO J. 1985. PMID: 3004953 Free PMC article.
-
OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.Immunol Rev. 2011 Nov;244(1):149-68. doi: 10.1111/j.1600-065X.2011.01062.x. Immunol Rev. 2011. PMID: 22017437 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources